STIM EBITDA | Neuronetics, Inc.

Neuronetics, Inc. (STIM) EBITDA

2026-06-30: Basis Reported; EBITDA -$772.00K*; Operating income -$1.50M; Depreciation and amortization $729.00K*.
2026-03-31: Basis Reported; EBITDA -$8.25M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$4.28M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$6.43M*; Operating income -$7.32M; Depreciation and amortization $886.00K*.

Complete source-backed ebitda history.

Available history: 2016-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$772.00K*	-$1.50M	$729.00K*	$41.57M	-1.86%*	(m)	-$1.01M*	$20.34M	$1.34M	(m)	(m)
2026-03-31	Reported	-$8.25M	(m)	(m)	(m)	-23.94%	(m)	-$9.42M	$18.30M	$1.36M	(m)	(m)
2025-12-31	Reported	-$4.28M	(m)	(m)	(m)	-10.24%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$6.43M*	-$7.32M	$886.00K*	$37.30M	-17.25%*	(m)	-$785.00K*	$20.19M	$1.50M	(m)	(m)
2025-06-30	Reported	-$7.16M*	-$8.06M	$901.00K*	$38.11M	-18.78%*	(m)	-$3.50M*	$20.35M	$1.80M	(m)	(m)
2025-03-31	Reported	-$10.1M	(m)	(m)	(m)	-31.60%	(m)	-$16.99M	$16.24M	$1.62M	(m)	(m)
2024-12-31	Reported	-$11.03M	(m)	(m)	(m)	-49.02%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$7.22M*	-$7.73M	$512.00K*	$18.53M	-38.94%*	(m)	-$5.42M*	$4.53M	$2.42M	$6.29M	$0.00
2024-06-30	Reported	-$7.95M*	-$8.51M	$555.00K*	$16.45M	-48.34%*	(m)	-$4.97M*	$4.27M	$2.23M	(m)	(m)
2024-03-31	Reported	-$6.3M	(m)	(m)	(m)	-36.17%	(m)	-$12.02M	$4.33M	$2.35M	(m)	(m)
2023-12-31	Reported	-$3.92M	(m)	(m)	(m)	-19.32%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$8.37M*	-$8.87M	$499.00K*	$17.36M	-48.21%*	(m)	$3.82M*	$6.12M	$137.77K	$5.99M	$0.00
2023-06-30	Reported	-$6.86M*	-$7.35M	$488.00K*	$17.61M	-38.96%*	(m)	-$8.83M*	$4.84M	$2.36M	(m)	(m)
2023-03-31	Reported	-$9.39M	(m)	(m)	(m)	-60.43%	(m)	-$15.21M	$4.14M	$2.79M	(m)	(m)
2022-12-31	Reported	-$7.12M	(m)	(m)	(m)	-39.14%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$7.07M*	-$7.45M	$387.00K*	$16.50M	-42.84%*	(m)	-$6.51M*	$3.57M	$2.35M	(m)	(m)
2022-06-30	Reported	-$9.46M*	-$9.80M	$338.00K*	$16.33M	-57.92%*	(m)	-$8.95M*	$4.04M	$2.04M	(m)	(m)
2022-03-31	Reported	-$9.82M	(m)	(m)	(m)	-69.22%	(m)	-$12.18M	$3.48M	$1.80M	(m)	(m)
2021-12-31	Reported	-$6.62M	(m)	(m)	(m)	-44.05%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$6.97M*	-$7.18M	$216.00K*	$13.80M	-50.48%*	(m)	-$8.52M*	$3.14M	$1.57M	(m)	(m)
2021-06-30	Reported	-$6.29M*	-$6.56M	$271.00K*	$14.20M	-44.31%*	(m)	-$5.77M*	$2.75M	$2.29M	(m)	(m)
2021-03-31	Reported	-$6.63M	(m)	(m)	(m)	-53.94%	(m)	-$9.17M	$2.22M	$2.31M	(m)	(m)
2020-12-31	Reported	-$2.46M	(m)	(m)	(m)	-15.79%	(m)	(m)	(m)	$2.11M	(m)	(m)
2020-09-30	Reported	-$2.22M*	-$2.42M	$207.00K*	$12.45M	-17.81%*	(m)	-$3.56M*	$2.66M	$1.95M	(m)	(m)
2020-06-30	Reported	-$6.63M*	-$6.86M	$233.00K*	$9.74M	-68.02%*	(m)	-$9.48M*	$2.32M	$2.12M	(m)	(m)
2020-03-31	Reported	-$10.07M	(m)	(m)	(m)	-87.70%	(m)	-$13.65M	$2.81M	$3.02M	(m)	(m)
2019-12-31	Reported	-$6.64M	(m)	(m)	(m)	-38.25%	(m)	(m)	(m)	$4.25M	(m)	(m)
2019-09-30	Reported	-$6.02M*	-$6.33M	$308.00K*	$16.00M	-37.63%*	(m)	-$7.66M*	$4.19M	$3.49M	(m)	(m)
2019-06-30	Reported	-$6.35M*	-$6.61M	$253.00K*	$16.57M	-38.34%*	(m)	-$6.85M*	$4.17M	$3.22M	(m)	(m)
2019-03-31	Reported	-$6.85M	(m)	(m)	(m)	-53.83%	(m)	-$9.57M	$2.81M	$2.79M	(m)	(m)
2018-12-31	Reported	-$5.45M	(m)	(m)	(m)	-34.86%	(m)	(m)	(m)	$2.22M	(m)	(m)
2018-09-30	Reported	-$4.12M*	-$4.33M	$208.00K*	$13.74M	-30.02%*	(m)	-$4.92M*	$3.03M	$2.13M	(m)	(m)
2018-06-30	Reported	-$4.91M*	-$5.24M	$324.00K*	$13.25M	-37.07%*	(m)	-$5.10M*	$3.25M	$2.33M	(m)	(m)
2018-03-31	Reported	-$4.47M	(m)	(m)	(m)	-43.99%	(m)	-$8.30M	$2.46M	$1.55M	(m)	(m)
2017-12-31	Reported	-$4.09M	(m)	(m)	(m)	-33.80%	(m)	(m)	(m)	$1.92M	(m)	(m)
2017-09-30	Reported	-$2.66M*	-$2.81M	$148.00K*	(m)	(m)	(m)	-$1.93M*	(m)	$1.84M	(m)	(m)
2017-06-30	Reported	(m)	-$2.58M	(m)	(m)	(m)	(m)	(m)	(m)	$2.15M	(m)	(m)
2017-03-31	Reported	(m)	-$3.99M	(m)	(m)	(m)	(m)	(m)	(m)	$2.03M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$27.97M	(m)	(m)	(m)	-18.75%	(m)	-$20.40M	$76.85M	$6.58M	(m)	(m)
2024-12-31	Reported	-$32.49M	(m)	(m)	(m)	-43.38%	(m)	-$31.00M	$20.73M	$12.77M	(m)	(m)
2023-12-31	Reported	-$28.55M	(m)	(m)	(m)	-40.01%	(m)	-$32.04M	$19.64M	$9.52M	(m)	(m)
2022-12-31	Reported	-$33.46M	(m)	(m)	(m)	-51.32%	(m)	-$30.74M	$15.48M	$9.34M	(m)	(m)
2021-12-31	Reported	-$26.5M	(m)	(m)	(m)	-47.92%	(m)	-$27.98M	$11.65M	$7.92M	(m)	(m)
2021-09-30	Rolling	(m)	-$23.32M*	(m)	(m)	(m)	(m)	(m)	(m)	$8.29M*	(m)	(m)
2021-06-30	Rolling	(m)	-$18.56M*	(m)	(m)	(m)	(m)	(m)	(m)	$8.67M*	(m)	(m)
2021-03-31	Rolling	(m)	-$18.85M*	(m)	(m)	(m)	(m)	(m)	(m)	$8.49M*	(m)	(m)
2020-12-31	Reported	-$21.37M	(m)	(m)	(m)	-43.39%	(m)	-$28.39M	$11.55M	$9.20M	(m)	(m)
2020-12-31	Rolling	(m)	-$22.31M*	(m)	(m)	(m)	(m)	(m)	(m)	$9.20M*	(m)	(m)
2020-09-30	Rolling	(m)	-$26.59M*	(m)	(m)	(m)	(m)	(m)	(m)	$11.34M*	(m)	(m)
2020-06-30	Rolling	(m)	-$30.49M*	(m)	(m)	(m)	(m)	(m)	(m)	$12.87M*	(m)	(m)
2020-03-31	Rolling	(m)	-$30.24M*	(m)	(m)	(m)	(m)	(m)	(m)	$13.98M*	(m)	(m)
2019-12-31	Reported	-$25.87M	(m)	(m)	(m)	-41.28%	(m)	-$30.48M	$15.39M	$13.75M	(m)	(m)
2019-12-31	Rolling	(m)	-$26.93M*	(m)	(m)	(m)	(m)	(m)	(m)	$13.75M*	(m)	(m)
2019-09-30	Rolling	(m)	-$25.65M*	(m)	(m)	(m)	(m)	(m)	(m)	$11.72M*	(m)	(m)
2019-06-30	Rolling	(m)	-$23.66M*	(m)	(m)	(m)	(m)	(m)	(m)	$10.36M*	(m)	(m)
2019-03-31	Rolling	(m)	-$22.29M*	(m)	(m)	(m)	(m)	(m)	(m)	$9.46M*	(m)	(m)
2018-12-31	Reported	-$18.95M	(m)	(m)	(m)	-35.91%	(m)	-$20.59M	$12.45M	$8.23M	(m)	(m)
2018-12-31	Rolling	(m)	-$19.83M*	(m)	(m)	(m)	(m)	(m)	(m)	$8.23M*	(m)	(m)
2018-09-30	Rolling	(m)	-$18.41M*	(m)	(m)	(m)	(m)	(m)	(m)	$7.93M*	(m)	(m)
2018-06-30	Rolling	(m)	-$16.88M*	(m)	(m)	(m)	(m)	(m)	(m)	$7.65M*	(m)	(m)
2018-03-31	Rolling	(m)	-$14.22M*	(m)	(m)	(m)	(m)	(m)	(m)	$7.46M*	(m)	(m)
2017-12-31	Reported	-$13.01M	(m)	(m)	(m)	-32.18%	(m)	-$11.14M	$9.63M	$7.94M	(m)	(m)
2017-12-31	Rolling	(m)	-$13.61M*	(m)	(m)	(m)	(m)	(m)	(m)	$7.94M*	(m)	(m)
2016-12-31	Reported	-$8.66M	(m)	(m)	(m)	-25.31%	(m)	-$8.54M	(m)	$8.22M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Profound Medical Corp. (PROF)		$0.206B	-7.37
PRO DEX INC (PDEX)	United States	$0.234B	13.64
UTAH MEDICAL PRODUCTS INC (UTMD)	United States	$0.238B	20.93
InfuSystem Holdings, Inc (INFU)	United States	$0.253B	22.52
Lucid Diagnostics Inc. (LUCD)	United States	$0.170B
Anika Therapeutics, Inc. (ANIK)	United States	$0.272B	-51.71
ORASURE TECHNOLOGIES INC (OSUR)	United States	$0.272B	-6.26
Cytosorbents Corp (CTSO)	United States	$0.274B	-1.29
KORU Medical Systems, Inc. (KRMD)	United States	$0.151B	-106.78
TriSalus Life Sciences, Inc. (TLSI)	United States	$0.283B	-9.92